Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130) Revenue Breakdown - Main Composition

31.57
-0.23-0.72%

Market Closed Mar 9 15:00 CST

2.41BMarket Cap61.42P/E (TTM)

Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130) Revenue Breakdown Overview

By Product

Currency:CNY

2025/H1

Stock NameRevenueRatio

利培酮口崩片59.07M46.03%

复方硫酸亚铁叶酸片49.22M38.36%

Total special adjustments19.24M14.99%

Other business784.98K0.61%

By Industry

Currency:CNY

2025/H1

Stock NameRevenueRatio

Pharmaceutical main business127.53M99.39%

Other business784.98K0.61%

By Country/Region

Currency:CNY

2025/H1

Stock NameRevenueRatio

South China22.31M17.38%

East China region19.3M15.04%

Central China18.57M14.48%

Northeast area18.08M14.09%

North China17.13M13.35%

Southwest area16.55M12.90%

Northwest region15.58M12.14%

Other business784.98K0.61%

View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Recently, the conflict between the US and Iran has continued, with the Strait of Hormuz at a standstill. A surge in oil prices, compounded b Show More

富哥搞钱

Feb 28 17:22

Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.